Diethylnorspermine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDiethylnorspermine
Drug Alias NameN-N-diethylnorspermineCI-1006DE-333DENSPMBENSPM +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionS-adenosylmethionine decarboxylase 1 inhibitorsOrnithine decarboxylase inhibitors
TargetsS-adenosylmethionine decarboxylase 1Ornithine decarboxylase
Therapy Area/IndicationsAlzheimer DiseasePancreatic NeoplasmsLiver Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiPfizer IncGenzyme Corp +[4] 
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseasePancreatic NeoplasmsLiver Neoplasms +[6] 

Other Information

ATC CodeN/A
Related LinksN/A